- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Teva, Mylan launch Viagra generics in Europe
- Roxane Labs' generic prostate drug gets tentative approval from FDA
- State of the market: Are generic drugs approaching their peak?
- Pfizer launches Robitussin Maximum Strength Cough + Congestion DM
PEAPACK, N.J. — The generics division of drug maker Pfizer is recalling supplies of two drugs due to possible mislabeling.
Greenstone announced Saturday that it would voluntarily recall 100-count bottles of citalopram 10-mg tablets and 90-count bottles of finasteride 5-mg tablets with the lot number FI0510058-A on the label. The company said a third-party manufacturer may have placed incorrect labels on the bottles. No other lots are affected.
Citalopram is used to treat depression, while finasteride is used to treat benign prostatic hyperplasia.